Related Experiment Video
Updated: May 5, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Spinal muscular atrophy type I in a 3.5-month-old male infant: A case report
Raja Nasir Nawaz1, Wafa Asjad1, Roshaan Bashir1
1Department of Paediatrics, Al-Nafees Medical College and Hospital, Islamabad, Pakistan.
Rationale:
Spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disorder that causes muscle weakness and hypotonia in infants due to survival motor neuron (SMN) protein degeneration. There are 5 recognized main subtypes of SMA, based on the age symptom onset, disease severity, and life expectancy. SMA type I (Werdnig-Hoffmann disease) is the most severe form, with symptom onset before 6 months of age.
Patient Concerns:
We report the case of a 3.5-month-old male infant who presented with complaints of feeding difficulty, weak sucking power, reduced muscle tone, tongue fasciculations, and delayed motor milestones since birth. There was no cognitive or sensory impairment.
Diagnoses:
Antenatal history revealed polyhydramnios and reduced fetal movements in the third trimester. Electromyography revealed severe motor neuropathy in lower limbs, and multiplex ligation-dependent probe amplification analysis confirmed homozygous deletion of the survival motor neuron 1 gene, establishing the diagnosis of SMA type I.
Interventions:
The patient was managed with supportive measures, including feeding support via a nasogastric tube, respiratory monitoring, and genetic counseling for the family.
Outcomes:
Regular follow-up was advised. Disease-modifying therapies were discussed, but were not available due to resource limitations.
Lessons:
Early recognition and diagnosis of SMA Type I are important to improve survival and clinical outcomes in the patient. Genetic counseling, establishing standardized diagnostic procedures, and ensuring access to new treatments are crucial for optimizing patient care.
More Related Videos
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
09:07Electrophysiological Motor Unit Number Estimation MUNE Measuring Compound Muscle Action Potential CMAP in Mouse Hindlimb Muscles
Published on: September 25, 2015
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Myasthenia Gravis ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...